169 related articles for article (PubMed ID: 10479183)
1. Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin.
Fischer P; Tukesiga E; Büttner DW
J Infect Dis; 1999 Oct; 180(4):1403-5. PubMed ID: 10479183
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human Mansonella streptocerca infection with ivermectin.
Fischer P; Bamuhiiga J; Büttner DW
Trop Med Int Health; 1997 Feb; 2(2):191-9. PubMed ID: 9472305
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Mansonella perstans in western Uganda and its detection using the QBC-fluorescence method.
Fischer P; Kilian AH; Bamuhiiga J; Kipp W; Büttner DW
Appl Parasitol; 1996 Jan; 37(1):32-7. PubMed ID: 8574245
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and diagnosis of Mansonella streptocerca in Uganda.
Fischer P; Bamuhiiga J; Büttner DW
Acta Trop; 1997 Jan; 63(1):43-55. PubMed ID: 9083584
[TBL] [Abstract][Full Text] [Related]
5. Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay.
Fischer P; Büttner DW; Bamuhiiga J; Williams SA
Am J Trop Med Hyg; 1998 Jun; 58(6):816-20. PubMed ID: 9660471
[TBL] [Abstract][Full Text] [Related]
6. A randomised, double-blind field trial of ivermectin alone and in combination with albendazole for the treatment of Mansonella perstans infections in Uganda.
Asio SM; Simonsen PE; Onapa AW
Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):274-9. PubMed ID: 19081121
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis.
Bregani ER; Rovellini A; Mbaïdoum N; Magnini MG
Trans R Soc Trop Med Hyg; 2006 May; 100(5):458-63. PubMed ID: 16257021
[TBL] [Abstract][Full Text] [Related]
8. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
[TBL] [Abstract][Full Text] [Related]
9. Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.
Fischer P; Kipp W; Kabwa P; Buttner DW
Am J Trop Med Hyg; 1995 Aug; 53(2):171-8. PubMed ID: 7677220
[TBL] [Abstract][Full Text] [Related]
10. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
[TBL] [Abstract][Full Text] [Related]
11. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin treatment of mansonellosis in Trinidad.
Gonzalez AA; Chadee DD; Rawlins SC
West Indian Med J; 1999 Dec; 48(4):231-4. PubMed ID: 10639847
[TBL] [Abstract][Full Text] [Related]
13. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.
Keiser PB; Coulibaly YI; Keita F; Traore D; Diallo A; Diallo DA; Semnani RT; Doumbo OK; Traore SF; Klion AD; Nutman TB
Am J Trop Med Hyg; 2003 Sep; 69(3):331-5. PubMed ID: 14628953
[TBL] [Abstract][Full Text] [Related]
15. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.
Kyelem D; Sanou S; Boatin B; Medlock J; Coulibaly S; Molyneux DH
Ann Trop Med Parasitol; 2003 Dec; 97(8):827-38. PubMed ID: 14754495
[TBL] [Abstract][Full Text] [Related]
16. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
17. Mansonella perstans causing symptomatic hypereosinophilia in a missionary family.
Fux CA; Chappuis B; Holzer B; Aebi C; Bordmann G; Marti H; Hatz C
Travel Med Infect Dis; 2006 Sep; 4(5):275-80. PubMed ID: 16905458
[TBL] [Abstract][Full Text] [Related]
18. Studies on filariasis in Bauchi State, Nigeria. II. The prevalence of human filariasis in Darazo Local Government area.
Anosike JC; Onwuliri CO
Appl Parasitol; 1994 Nov; 35(4):242-50. PubMed ID: 7812311
[TBL] [Abstract][Full Text] [Related]
19. Ivermectin-related adverse clinical events in patients treated for Mansonella ozzardi infections.
Krolewiecki AJ; Cajal SP; Villalpando C; Gil JF
Rev Argent Microbiol; 2011; 43(1):48-50. PubMed ID: 21491068
[TBL] [Abstract][Full Text] [Related]
20. Case report: effects of diethylcarbamazine and thiabendazole combination against Mansonella perstans filariasis.
Bregani ER; Tantardini F; Rovellini A
Parassitologia; 2007 Jun; 49(1-2):37-8. PubMed ID: 18412041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
